EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Analysis of Gut Microbiota in Patients with Irritable Bowel Syndrome and Healthy Controls

Pedro Sánchez-Pellicer iD, José María Álamo-Marzo, María Martínez-Villaescusa iD, Eva Núñez-Delegido, José Francisco Such-Ronda, Francisco Huertas-López, Emilio Manuel Serrano-López, David Martínez-Moreno, Vicente Navarro-López iD

Journal of Clinical Medicine · 12.02.2025 · 14 (4) · 1198

DOI: 10.3390/jcm14041198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.02.2025. Verfasst von Pedro Sánchez-Pellicer und 8 weiteren Autor:innen. Beteiligte Einrichtung: MiBioPath Research Group, Faculty of Medicine, Universidad Católica San Antonio de Murcia, 30107 Murcia, Spain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Growing evidence highlights the pivotal role of gut dysbiosis in the pathophysiology of irritable bowel syndrome (IBS). Despite this, the identification of an “IBS microbiota signature” remains elusive, primarily due to the influence of genetic, dietary, and environmental factors. To address these confounding variables, it is critical to perform comparative analyses using a control group derived from the same community as the IBS patients. This study aimed to evaluate and contrast the gut microbiota composition of IBS patients with healthy controls.

Methods

We compared the gut microbiota from stool samples of 25 IBS patients diagnosed according to the Rome IV criteria, and 110 healthy subjects without acute or chronic diseases and not on continuous medication. The high-throughput sequencing of the V3–V4 regions of the 16S rRNA gene was conducted for microbiota analysis.

Results

The IBS gut microbiota was richer but exhibited lower alpha diversity compared to the control group, suggesting simplification and imbalance. A beta diversity analysis revealed overall compositional differences between the two groups. A heat tree analysis highlighted key IBS-associated changes, including a decrease in Firmicutes, mainly due to Clostridia, and an increase in Bacteroidota, driven by an expansion of Bacteroidales families. Differential expression analyses identified important genera within these taxa like Bacteroides, Faecalibacterium, and Blautia, which could serve as microbiota-based biomarkers for IBS.

Conclusions

Our results reveal both statistically and clinically significant differences in gut microbiota composition and diversity between IBS patients and healthy controls from the same community. These findings provide a deeper understanding of how alterations in the gut microbiota may contribute to IBS symptoms, offering new insights into the diagnosis and potential treatments.

Schlagwörter

Stichwörter der Autor:innen

functional colonic diseasesgastrointestinal microbiomehigh-throughput nucleotide sequencingirritable bowel syndromemicrobiota

Autor:innen und Institutionen

  • MiBioPath Research Group, Faculty of Medicine, Universidad Católica San Antonio de Murcia, 30107 Murcia, Spain.
  • Department of Clinical Laboratory, Hospital General Universitario Dr. Balmis, 03010 Alicante, Spain.
  • Department of Gastroenterology, Hospital Vithas Medimar, 03013 Alicante, Spain.
  • Marbyt-Smart Solutions for Biotechnology S. L., 30100 Murcia, Spain.

ORCID-Profile: Pedro Sánchez-Pellicer, María Martínez-Villaescusa, Vicente Navarro-López

Zitieren

APA

Sánchez-Pellicer, P., Álamo-Marzo, J. M., Martínez-Villaescusa, M., Núñez-Delegido, E., Such-Ronda, J. F., Huertas-López, F., Serrano-López, E. M., Martínez-Moreno, D., & Navarro-López, V. (2025). Comparative Analysis of Gut Microbiota in Patients with Irritable Bowel Syndrome and Healthy Controls. Journal of Clinical Medicine, 14(4), 1198. https://doi.org/10.3390/jcm14041198

Vancouver

Sánchez-Pellicer P, Álamo-Marzo JM, Martínez-Villaescusa M, Núñez-Delegido E, Such-Ronda JF, Huertas-López F, et al. Comparative Analysis of Gut Microbiota in Patients with Irritable Bowel Syndrome and Healthy Controls. Journal of Clinical Medicine. 2025;14(4):1198. doi:10.3390/jcm14041198

BibTeX
@article{SnchezPellicer2025,
  author = {Sánchez-Pellicer, Pedro and Álamo-Marzo, José María and Martínez-Villaescusa, María and Núñez-Delegido, Eva and Such-Ronda, José Francisco and Huertas-López, Francisco and Serrano-López, Emilio Manuel and Martínez-Moreno, David and Navarro-López, Vicente},
  title = {Comparative Analysis of Gut Microbiota in Patients with Irritable Bowel Syndrome and Healthy Controls},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1198},
  doi = {10.3390/jcm14041198}
}
Kostenlos starten →